No profile data available.
Cardiol Therapeutics Inc. (CRDL) is a healthcare company in the cardiac treatment pharmaceuticals industry, based in Oakville, Canada, with about 18 full-time employees.
In Q3 2025 (the quarter ended September 30, 2025) revenue was 0 CAD. Its market capitalization was $149.46 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
$149.46 million as of October 9, 2026.
Listed companies of a similar size in the same industry (cardiac treatment pharmaceuticals) include Cytokinetics, Incorporated (CYTK), Lexicon Pharmaceuticals, Inc. (LXRX), Lexeo Therapeutics, Inc. (LXEO), Tenaya Therapeutics, Inc. (TNYA).